Merck & Co Inc (MRK) Stock Analysis
Verdict: BUY
Merck's strong pipeline and Keytruda cash flow drive top-tier growth, but heavy insider selling and 2028 patent cliff risks linger.
Investment score: 66/100
Analysis as of
Is Merck & Co Inc stock worth reviewing? AI model thesis
The model score of 66/100 falls in the BUY range. The central thesis and factor breakdown explain the assessment.
7-factor investment score
- Valuation: 62/100 (weight 20%)
- Financial Health: 72/100 (weight 15%)
- Technical Momentum: 78/100 (weight 15%)
- Earnings Quality: 75/100 (weight 15%)
- Insider Sentiment: 25/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 68/100 (weight 15%)
Merck & Co Inc opportunities and risks
What speaks for MRK
- Forward earnings acceleration compresses P/E to attractive levels
What speaks against MRK
- Revenue concentration and Keytruda patent expiry risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MRK | 115.0x | 5.4x | 29.3x | 75.4% | 4.8% | 4.5% |
| LLY | 38.1x | 13.5x | 25.8x | 83.4% | 33.5% | 1.9% |
| JNJ | 30.9x | 6.6x | 19.9x | 67.9% | 21.5% | 2.9% |
| PFE | 36.3x | 2.5x | 17.3x | 71.3% | 6.8% | 7.0% |
| BMY | 14.0x | 2.6x | 9.9x | 70.2% | 18.9% | 8.8% |
| RPRX | 24.3x | 10.2x | 19.9x | 89.4% | 32.1% | 11.5% |
| Peer median | 30.9x | 6.6x | 19.9x | 71.3% | 21.5% | 7.0% |
Frequently asked questions about Merck & Co Inc (MRK)
Is MRK stock a good investment?
The cached TradeMates AI model rates Merck & Co Inc as BUY with an investment score of 66/100. The model score of 66/100 falls in the BUY range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.
Is MRK stock a buy?
The TradeMates model verdict for MRK is BUY with an investment score of 66/100. Treat this as a model signal to review, not a personal buy recommendation.